HDAC1-mediated inhibition of hepatocyte markers is a critical stage in the formation of hepatoblastoma, laying the groundwork for the development of treatments for aggressive hepatoblastoma by inhibiting HDAC1 activity35. Here, HDAC1 is linked to hepatoblastoma.